BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 17803871)

  • 1. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.
    Green H; Paul M; Vidal L; Leibovici L
    Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
    Stern A; Green H; Paul M; Vidal L; Leibovici L
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumocystis pneumonia in patients with immunosuppression other than HIV infection].
    Adler D; Chenivesse C; Similowski T; Soccal PM
    Rev Med Suisse; 2008 Nov; 4(180):2525-6, 2528-30. PubMed ID: 19127897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
    Evans RA; Clifford TM; Tang S; Au T; Fugit AM
    Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
    Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
    J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
    Kato H; Samukawa S; Takahashi H; Nakajima H
    J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Vananuvat P; Suwannalai P; Sungkanuparph S; Limsuwan T; Ngamjanyaporn P; Janwityanujit S
    Semin Arthritis Rheum; 2011 Dec; 41(3):497-502. PubMed ID: 21959291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
    Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.
    Anand S; Samaniego M; Kaul DR
    Transpl Infect Dis; 2011 Dec; 13(6):570-4. PubMed ID: 22093215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
    Chokephaibulkit K; Wanachiwanawin D; Chearskul S; Wanprapa N; Unganont K; Tantinikorn W; Udompunthurak S
    Pediatr Infect Dis J; 1999 Feb; 18(2):147-52. PubMed ID: 10048687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
    Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis carinii pneumonia: pitfalls of prophylaxis.
    Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P
    J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.